[1]
I. S. Krysanov, V. S. Krysanova, and V. . Yu, “Clinical and Economic Aspects of the First Biosimilar Eculizumab use in Patients with Rare Diseases”, CTBP, vol. 16, no. 2, pp. 223–234, May 2022.